CD1D and cancer: Myeloma cells that express CD1d are sensitive to lysis by iNKT cells, but the CD1d expression is almost totally lost in the advanced stages of MM and in the myeloma cell lines (185, 186) as part of the immune evasion mechanisms of this cancer by contributing to iNKT cell anergy in MM (3).